TY - JOUR
T1 - External Validation of a Retinopathy of Prematurity Screening Model Using Artificial Intelligence in 3 Low- and Middle-Income Populations
AU - Coyner, Aaron S.
AU - Oh, Minn A.
AU - Shah, Parag K.
AU - Singh, Praveer
AU - Ostmo, Susan
AU - Valikodath, Nita G.
AU - Cole, Emily
AU - Al-Khaled, Tala
AU - Bajimaya, Sanyam
AU - K.c, Sagun
AU - Chuluunbat, Tsengelmaa
AU - Munkhuu, Bayalag
AU - Subramanian, Prema
AU - Venkatapathy, Narendran
AU - Jonas, Karyn E.
AU - Hallak, Joelle A.
AU - Chan, R. V.Paul
AU - Chiang, Michael F.
AU - Kalpathy-Cramer, Jayashree
AU - Campbell, J. Peter
N1 - Funding Information:
Author Contributions: Drs Coyner and Campbell had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Kalpathy-Cramer and Campbell supervised this work equally. Concept and design: Coyner, Oh, Singh, Bajimaya, Munkhuu, Venkatapathy, Jonas, Hallak, Chiang, Kalpathy-Cramer, Campbell. Acquisition, analysis, or interpretation of data: Coyner, Oh, Shah, Singh, Ostmo, Valikodath, Cole, Al-Khaled, K.C., Chuluunbat, Munkhuu, Subramanian, Jonas, Hallak, Chan, Kalpathy-Cramer, Campbell. Drafting of the manuscript: Coyner, Oh, Singh, Valikodath, Bajimaya, Chuluunbat, Kalpathy-Cramer, Campbell. Critical revision of the manuscript for important intellectual content: Coyner, Shah, Singh, Ostmo, Cole, Al-Khaled, K.C., Munkhuu, Subramanian, Venkatapathy, Jonas, Hallak, Chan, Chiang, Kalpathy-Cramer, Campbell. Statistical analysis: Coyner, Oh, Hallak. Obtained funding: Kalpathy-Cramer, Campbell. Administrative, technical, or material support: Oh, Shah, Singh, Ostmo, Cole, K.C., Venkatapathy, Jonas, Chiang, Kalpathy-Cramer. Supervision: Munkhuu, Subramanian, Kalpathy-Cramer, Campbell. Conflict of Interest Disclosures: The i-ROP DL system has been licensed by Massachusetts General Hospital and Oregon Health & Science University to Boston AI and Siloam Vision and may result in royalties to Drs. Coyner, Chan, Kalpathy-Cramer, and Campbell in the future. These conflicts are managed by each respective institution. Dr Hallak reported being an employee of AbbVie outside the submitted work. Dr Chan reported being an equity owner of Siloam Vision outside the submitted work. Dr Chiang reported receiving research support from the National Institutes of Health, the National Science Foundation, and Genentech; personal fees from Novartis; and having equity from InTeleretina outside the submitted work. Dr Kalpathy-Cramer reported receiving grants from the National Institutes of Health, GE, Bayer, and Genentech outside the submitted work. Dr Campbell reported receiving research support from the National Institutes of Health, the National Science Foundation, and Genentech outside the submitted work; consulting fees from Boston AI; and being an equity owner of Siloam Vision outside the submitted work. No other disclosures were reported.
Funding Information:
grants R01 EY019474, R01 EY031331, R21 EY031883, and P30 EY10572 from the National Institutes of Health (Bethesda, MD), and by unrestricted departmental funding and a Career Development Award (Dr Campbell) from Research
Publisher Copyright:
© 2022 American Medical Association. All rights reserved.
PY - 2022/8
Y1 - 2022/8
N2 - Importance: Retinopathy of prematurity (ROP) is a leading cause of preventable blindness that disproportionately affects children born in low- and middle-income countries (LMICs). In-person and telemedical screening examinations can reduce this risk but are challenging to implement in LMICs owing to the multitude of at-risk infants and lack of trained ophthalmologists. Objective: To implement an ROP risk model using retinal images from a single baseline examination to identify infants who will develop treatment-requiring (TR)-ROP in LMIC telemedicine programs. Design, Setting, and Participants: In this diagnostic study conducted from February 1, 2019, to June 30, 2021, retinal fundus images were collected from infants as part of an Indian ROP telemedicine screening program. An artificial intelligence (AI)-derived vascular severity score (VSS) was obtained from images from the first examination after 30 weeks' postmenstrual age. Using 5-fold cross-validation, logistic regression models were trained on 2 variables (gestational age and VSS) for prediction of TR-ROP. The model was externally validated on test data sets from India, Nepal, and Mongolia. Data were analyzed from October 20, 2021, to April 20, 2022. Main Outcomes and Measures: Primary outcome measures included sensitivity, specificity, positive predictive value, and negative predictive value for predictions of future occurrences of TR-ROP; the number of weeks before clinical diagnosis when a prediction was made; and the potential reduction in number of examinations required. Results: A total of 3760 infants (median [IQR] postmenstrual age, 37 [5] weeks; 1950 male infants [51.9%]) were included in the study. The diagnostic model had a sensitivity and specificity, respectively, for each of the data sets as follows: India, 100.0% (95% CI, 87.2%-100.0%) and 63.3% (95% CI, 59.7%-66.8%); Nepal, 100.0% (95% CI, 54.1%-100.0%) and 77.8% (95% CI, 72.9%-82.2%); and Mongolia, 100.0% (95% CI, 93.3%-100.0%) and 45.8% (95% CI, 39.7%-52.1%). With the AI model, infants with TR-ROP were identified a median (IQR) of 2.0 (0-11) weeks before TR-ROP diagnosis in India, 0.5 (0-2.0) weeks before TR-ROP diagnosis in Nepal, and 0 (0-5.0) weeks before TR-ROP diagnosis in Mongolia. If low-risk infants were never screened again, the population could be effectively screened with 45.0% (India, 664/1476), 38.4% (Nepal, 151/393), and 51.3% (Mongolia, 266/519) fewer examinations required. Conclusions and Relevance: Results of this diagnostic study suggest that there were 2 advantages to implementation of this risk model: (1) the number of examinations for low-risk infants could be reduced without missing cases of TR-ROP, and (2) high-risk infants could be identified and closely monitored before development of TR-ROP..
AB - Importance: Retinopathy of prematurity (ROP) is a leading cause of preventable blindness that disproportionately affects children born in low- and middle-income countries (LMICs). In-person and telemedical screening examinations can reduce this risk but are challenging to implement in LMICs owing to the multitude of at-risk infants and lack of trained ophthalmologists. Objective: To implement an ROP risk model using retinal images from a single baseline examination to identify infants who will develop treatment-requiring (TR)-ROP in LMIC telemedicine programs. Design, Setting, and Participants: In this diagnostic study conducted from February 1, 2019, to June 30, 2021, retinal fundus images were collected from infants as part of an Indian ROP telemedicine screening program. An artificial intelligence (AI)-derived vascular severity score (VSS) was obtained from images from the first examination after 30 weeks' postmenstrual age. Using 5-fold cross-validation, logistic regression models were trained on 2 variables (gestational age and VSS) for prediction of TR-ROP. The model was externally validated on test data sets from India, Nepal, and Mongolia. Data were analyzed from October 20, 2021, to April 20, 2022. Main Outcomes and Measures: Primary outcome measures included sensitivity, specificity, positive predictive value, and negative predictive value for predictions of future occurrences of TR-ROP; the number of weeks before clinical diagnosis when a prediction was made; and the potential reduction in number of examinations required. Results: A total of 3760 infants (median [IQR] postmenstrual age, 37 [5] weeks; 1950 male infants [51.9%]) were included in the study. The diagnostic model had a sensitivity and specificity, respectively, for each of the data sets as follows: India, 100.0% (95% CI, 87.2%-100.0%) and 63.3% (95% CI, 59.7%-66.8%); Nepal, 100.0% (95% CI, 54.1%-100.0%) and 77.8% (95% CI, 72.9%-82.2%); and Mongolia, 100.0% (95% CI, 93.3%-100.0%) and 45.8% (95% CI, 39.7%-52.1%). With the AI model, infants with TR-ROP were identified a median (IQR) of 2.0 (0-11) weeks before TR-ROP diagnosis in India, 0.5 (0-2.0) weeks before TR-ROP diagnosis in Nepal, and 0 (0-5.0) weeks before TR-ROP diagnosis in Mongolia. If low-risk infants were never screened again, the population could be effectively screened with 45.0% (India, 664/1476), 38.4% (Nepal, 151/393), and 51.3% (Mongolia, 266/519) fewer examinations required. Conclusions and Relevance: Results of this diagnostic study suggest that there were 2 advantages to implementation of this risk model: (1) the number of examinations for low-risk infants could be reduced without missing cases of TR-ROP, and (2) high-risk infants could be identified and closely monitored before development of TR-ROP..
UR - http://www.scopus.com/inward/record.url?scp=85134403767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134403767&partnerID=8YFLogxK
U2 - 10.1001/jamaophthalmol.2022.2135
DO - 10.1001/jamaophthalmol.2022.2135
M3 - Article
C2 - 35797036
AN - SCOPUS:85134403767
SN - 2168-6165
VL - 140
SP - 791
EP - 798
JO - JAMA ophthalmology
JF - JAMA ophthalmology
IS - 8
ER -